JPWO2021046331A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021046331A5 JPWO2021046331A5 JP2022514481A JP2022514481A JPWO2021046331A5 JP WO2021046331 A5 JPWO2021046331 A5 JP WO2021046331A5 JP 2022514481 A JP2022514481 A JP 2022514481A JP 2022514481 A JP2022514481 A JP 2022514481A JP WO2021046331 A5 JPWO2021046331 A5 JP WO2021046331A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- immunoglobulin
- variable domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962896415P | 2019-09-05 | 2019-09-05 | |
| US62/896,415 | 2019-09-05 | ||
| PCT/US2020/049377 WO2021046331A1 (en) | 2019-09-05 | 2020-09-04 | Anti-steap1 antibodies and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022546572A JP2022546572A (ja) | 2022-11-04 |
| JPWO2021046331A5 true JPWO2021046331A5 (https=) | 2023-09-11 |
| JP2022546572A5 JP2022546572A5 (https=) | 2023-09-11 |
| JP7805287B2 JP7805287B2 (ja) | 2026-01-23 |
Family
ID=74853055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514481A Active JP7805287B2 (ja) | 2019-09-05 | 2020-09-04 | 抗ｓｔｅａｐ１抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220348686A1 (https=) |
| EP (1) | EP4025609A4 (https=) |
| JP (1) | JP7805287B2 (https=) |
| KR (1) | KR20220057575A (https=) |
| CN (1) | CN114929743B (https=) |
| AU (1) | AU2020343652A1 (https=) |
| CA (1) | CA3150149A1 (https=) |
| IL (1) | IL291027A (https=) |
| WO (1) | WO2021046331A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240415888A1 (en) * | 2021-10-20 | 2024-12-19 | Memorial Sloan Kettering Cancer Center | Anti-tshr multi-specific antibodies and uses thereof |
| GB202208119D0 (en) * | 2022-06-01 | 2022-07-13 | Univ Oslo Hf | Anti-steap1 car |
| CA3261989A1 (en) * | 2022-07-22 | 2024-01-25 | Genentech, Inc. | ANTI-STEAP1 ANTIGEN-BINDING MOLECULES AND THEIR USES |
| US20260042860A1 (en) * | 2022-08-04 | 2026-02-12 | Memorial Sloan-Kettering Cancer Center | Anti-cd24 antibodies and uses thereof |
| AU2024243972A1 (en) * | 2023-04-06 | 2025-10-23 | Memorial Hospital For Cancer And Allied Diseases | Il-10 receptor antibodies and methods of use thereof |
| WO2025042872A1 (en) * | 2023-08-21 | 2025-02-27 | Amgen Research (Munich) Gmbh | Combination therapy for treating prostate cancer |
| WO2025042865A1 (en) * | 2023-08-21 | 2025-02-27 | Amgen Research (Munich) Gmbh | Methods for treating prostate cancer with bispecific antibodies binding steap1xcd3 |
| WO2025128807A1 (en) * | 2023-12-13 | 2025-06-19 | Amgen Inc. | Radiolabeled compounds for the detection of steap1 |
| CN119113151B (zh) * | 2024-08-01 | 2025-11-18 | 华中科技大学同济医学院附属同济医院 | 一种前列腺癌特异性细胞外囊泡荧光探针及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2443996T3 (es) * | 2004-04-22 | 2014-02-21 | Agensys, Inc. | Anticuerpos y moléculas derivadas de los mismos que se unen a proteínas STEAP-1 |
| CN101573384B (zh) * | 2006-10-27 | 2013-02-20 | 健泰科生物技术公司 | 抗体和免疫偶联物及其用途 |
| KR20140116546A (ko) * | 2006-10-27 | 2014-10-02 | 제넨테크, 인크. | 항체 및 면역접합체 및 이들의 용도 |
| GB0917044D0 (en) * | 2009-09-29 | 2009-11-18 | Cytoguide As | Agents, uses and methods |
| RU2613886C2 (ru) * | 2010-06-03 | 2017-03-21 | Дженентек, Инк. | Антитела и иммуноконъюгаты, визуализируемые при помощи иммуно-позитрон-эмиссионной томографии, и способы их применения |
| BR112014012882A2 (pt) * | 2011-11-29 | 2017-06-13 | Genentech Inc | método, anticorpo, polinucleotídeo, célula hospedeira, linhagem celular de hibridoma, uso do anticorpo e kit |
| KR101911438B1 (ko) * | 2012-10-31 | 2018-10-24 | 삼성전자주식회사 | 이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법 |
| US20170043034A1 (en) * | 2014-01-24 | 2017-02-16 | Genentech, Inc. | Methods of using anti-steap1 antibodies and immunoconjugates |
| MX2017003123A (es) * | 2014-09-12 | 2017-05-12 | Genentech Inc | Anticuerpos y conjugados modificados geneticamente con cisteina. |
| CN113552350B (zh) * | 2015-04-21 | 2024-10-11 | 基因泰克公司 | 用于前列腺癌分析的组合物和方法 |
| KR20180023949A (ko) * | 2015-06-09 | 2018-03-07 | 메모리얼 슬로안-케터링 캔서 센터 | 인간 hla에 의해 제시된 ebv 잠복성 막 단백질 2a 펩티드에 특이적인 t 세포 수용체-유사 항체 작용제 |
| WO2017055388A2 (en) * | 2015-10-02 | 2017-04-06 | F. Hoffmann-La Roche Ag | Bispecific t cell activating antigen binding molecules |
| US11046768B2 (en) * | 2017-01-27 | 2021-06-29 | Memorial Sloan Kettering Cancer Center | Bispecific HER2 and CD3 binding molecules |
| SG11201909218RA (en) * | 2017-04-03 | 2019-11-28 | Hoffmann La Roche | Antibodies binding to steap-1 |
| US12084514B2 (en) * | 2017-12-04 | 2024-09-10 | The Board Of Regents Of The University Of Oklahoma | Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof |
| EP3938400B1 (en) * | 2019-03-11 | 2025-07-30 | Memorial Sloan Kettering Cancer Center | Cd22 antibodies and methods of using the same |
-
2020
- 2020-09-04 JP JP2022514481A patent/JP7805287B2/ja active Active
- 2020-09-04 AU AU2020343652A patent/AU2020343652A1/en active Pending
- 2020-09-04 CA CA3150149A patent/CA3150149A1/en active Pending
- 2020-09-04 US US17/640,598 patent/US20220348686A1/en active Pending
- 2020-09-04 KR KR1020227011015A patent/KR20220057575A/ko active Pending
- 2020-09-04 EP EP20860238.3A patent/EP4025609A4/en active Pending
- 2020-09-04 CN CN202080076671.XA patent/CN114929743B/zh active Active
- 2020-09-04 WO PCT/US2020/049377 patent/WO2021046331A1/en not_active Ceased
-
2022
- 2022-03-01 IL IL291027A patent/IL291027A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101228124B1 (ko) | 단클론 항체 ｐａｍ4 및 췌장암의 진단 및 치료를 위한이들의 용도 | |
| IL273484B1 (en) | A33 antibody compositions and methods of using the same in radioimmunotherapy | |
| JP2020523029A5 (https=) | ||
| US8198411B2 (en) | Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer | |
| Chester et al. | Engineering antibodies for clinical applications in cancer | |
| JP2021517816A5 (https=) | ||
| Luo et al. | Design and applications of bispecific heterodimers: molecular imaging and beyond | |
| JP2020534017A5 (https=) | ||
| WO2019052508A1 (zh) | 放射性标记抗纳米抗体在癌症的预后、诊断中的应用 | |
| US20220056146A1 (en) | Antibodies and Antigen Binding Fragments Against CD155 Methods of Use Thereof | |
| Sirk et al. | Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2 | |
| Chester et al. | Clinical applications of phage‐derived sFvs and sFv fusion proteins | |
| JPWO2021046331A5 (https=) | ||
| JPWO2020210232A5 (https=) | ||
| JPWO2020264211A5 (https=) | ||
| JPWO2021216972A5 (https=) | ||
| JPWO2022032004A5 (https=) | ||
| CA3229327A1 (en) | Antibodies and antigen binding fragments against cd155 methods of use thereof | |
| Stocchi et al. | Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer | |
| JPWO2019178218A5 (https=) | ||
| JPWO2023014809A5 (https=) | ||
| US11427646B2 (en) | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | |
| US20250340662A1 (en) | Binding protein | |
| CN119505001B (zh) | 靶向cd22的全人源抗体及其应用 | |
| JPWO2023014810A5 (https=) |